Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prevention of
malaria
transmission throughout much of Africa is dependent on bednets that are impregnated with pyrethroid insecticides. Anopheles arabiensis is the major
malaria
vector in Chad and efforts to control this vector are threatened by the emergence of pyrethroid resistance. WHO bioassays revealed that An. arabiensis from Ndjamena is resistant to pyrethroids and dichlorodiphenyltrichloroethane (DDT) but fully susceptible to carbamates and organophosphates. No 1014F or 1014S kdr alleles were detected in this population. To determine the mechanisms that are responsible for resistance, genetic crosses were established between the Ndja strain and an insecticide susceptible population from Mozambique. Resistance was inherited as an autosomal trait and quantitative trait locus (QTL) mapping identified a single major locus on chromosome 2R, which explained 24.4% of the variance in resistance. This QTL is enriched in P450 genes including 25 cytochrome P450s in total. One of these, Cyp6p4 is 22-fold upregulated in the Ndja strain compared with the susceptible.
Piperonyl butoxide
(PBO) synergist and biochemical assays further support a role for P450s in conferring pyrethroid resistance in this population.
...
PMID:Genetic mapping identifies a major locus spanning P450 clusters associated with pyrethroid resistance in kdr-free Anopheles arabiensis from Chad. 2329
Growing insecticide resistance in
malaria
vectors is threatening the effectiveness of insecticide-based interventions, including Long Lasting Insecticidal Nets (LLINs). However, the impact of metabolic resistance on the effectiveness of these tools remains poorly characterized. Using experimental hut trials and genotyping of a glutathione S-transferase resistance marker (L119F-
GSTe2
), we established that GST-mediated resistance is reducing the efficacy of LLINs against
Anopheles funestus
. Hut trials performed in Cameroon revealed that
Piperonyl butoxide
(PBO)-based nets induced a significantly higher mortality against pyrethroid resistant
An. funestus
than pyrethroid-only nets. Blood feeding rate and deterrence were significantly higher in all LLINs than control. Genotyping the L119F-
GSTe2
mutation revealed that, for permethrin-based nets, 119F-
GSTe2
resistant mosquitoes have a greater ability to blood feed than susceptible while the opposite effect is observed for deltamethrin-based nets. For Olyset Plus, a significant association with exophily was observed in resistant mosquitoes (OR = 11.7;
p
< 0.01). Furthermore,
GSTe2
-resistant mosquitoes (cone assays) significantly survived with PermaNet 2.0 (OR = 2.1;
p
< 0.01) and PermaNet 3.0 (side) (OR = 30.1;
p
< 0.001) but not for Olyset Plus. This study shows that the efficacy of PBO-based nets (e.g., blood feeding inhibition) against pyrethroid resistant
malaria
vectors could be impacted by other mechanisms including GST-mediated metabolic resistance not affected by the synergistic action of PBO. Mosaic LLINs incorporating a GST inhibitor (diethyl maleate) could help improve their efficacy in areas of GST-mediated resistance.
...
PMID:An Experimental Hut Evaluation of PBO-Based and Pyrethroid-Only Nets against the Malaria Vector
Anopheles funestus
Reveals a Loss of Bed Nets Efficacy Associated with
GSTe2
Metabolic Resistance. 3201 27
The emergence and spread of insecticide resistance among the main
malaria
vectors is threatening the effectiveness of vector control interventions in Senegal. The main drivers of this resistance in the
Anopheles gambiae
complex (e.g.,
An. gambiae
and
Anopheles coluzzii
) remains poorly characterized in Senegal. Here we characterized the main target site and metabolic resistances mechanisms among the
An. gambiae
and
An. coluzzii
populations from their sympatric and allopatric or predominance area in Senegal. Larvae and pupae of
An. gambiae
s.l. were collected, reared to adulthood, and then used for insecticides susceptibility and synergist assays using the WHO (World Health Organisation) test kits for adult mosquitoes. The TaqMan method was used for the molecular characterization of the main target site insecticide resistance mechanisms (Vgsc-1014F, Vgsc-1014S, N1575Y and G119S). A RT-qPCR (Reverse Transcriptase-quantitative Polymerase Chaine Reaction) was performed to estimate the level of genes expression belonging to the CYP450 (Cytochrome P450) family.
Plasmodium
infection rate was investigated using TaqMan method. High levels of resistance to pyrethroids and DDT and full susceptibility to organophosphates and carbamates where observed in all three sites, excepted a probable resistance to bendiocarb in Kedougou. The L1014F, L1014S, and N1575Y mutations were found in both species. Pre-exposure to the PBO (
Piperonyl butoxide
) synergist induced a partial recovery of susceptibility to permethrin and full recovery to deltamethrin. Subsequent analysis of the level of genes expression, revealed that the
CYP6Z1
and
CYP6Z2
genes were over-expressed in wild-resistant mosquitoes compared to the reference susceptible strain (Kisumu), suggesting that both the metabolic resistance and target site mutation involving
kdr
mutations are likely implicated in this pyrethroid resistance. The presence of both target-site and metabolic resistance mechanisms in highly pyrethroid-resistant populations of
An. gambiae
s.l. from Senegal threatens the effectiveness and the sustainability of the pyrethroid-based tools and interventions currently deployed in the country. The
Kdr-west
mutation is widely widespread in
An. coluzzii
sympatric population. PBO or Duo nets and IRS (Indoor Residual Spraying) with organophosphates could be used as an alternative measure to sustain
malaria
control in the study area.
...
PMID:Insecticide Resistance Profiling of
Anopheles coluzzii
and
Anopheles gambiae
Populations in the Southern Senegal: Role of Target Sites and Metabolic Resistance Mechanisms. 3325 5